5-Bromo-2-chlorobenzoic acid
				 - 
			Dapagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				 Apixaban 
				 - 
			Apixaban 
Cardiovasculars
			 | 
		
		 | 
		
			
				 
				
				 Aripiprazole 
				 - 
			Aripiprazole 
Anti-Psychotic
			 | 
		
		 | 
		
			
				 
				
				 Saxagliptin hydrate 
				 - 
			Saxagliptin
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				 Tenofovir disoproxil fumarate
				 - 
			Tenofovir
HIV
			 | 
		
		 | 
		
			
				 
				
				(1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium
				 - 
			Ticagrelor intermediates
			 | 
		
		 | 
		
			
				 
				
				(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester
				 - 
			Saxagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile
				 - 
			Vildagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
				 - 
			Teneligliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
				 - 
			Sitagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
				 - 
			Sitagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan 
				 - 
			Empagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan
				 - 
			Empagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
				 - 
			Dapagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				(R)-3-(Boc-Amino)piperidine
				 - 
			Alogliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(R)-3-Aminopiperidine dihydrochloride
				 - 
			Alogliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				(R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				(S)-(+)-N-(2,3-Epoxypropyl)phthalimide
				 - 
			Rivaroxaban intermediates
			 | 
		
		 | 
		
			
				 
				
				(S)-3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine, N-acetyl-glutarate
				 - 
			Repaglinide intermediates
			 | 
		
		 | 
		
			
				 
				
				1-(2,3-Dichlorophenyl)piperazine hydrochloride
				 - 
			Aripiprazole intermediates
			 | 
		
		 | 
		
			
				 
				
				1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine
				 - 
			Teneligliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4);5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride (1:4) 
				 - 
			Daclatasvir Intermediates
			 | 
		
		 | 
		
			
				 
				
				1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)- 
				 - 
			Daclatasvir Intermediates
			 | 
		
		 | 
		
			
				 
				
				2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid
				 - 
			Ticagrelor intermediates
			 | 
		
		 | 
		
			
				 
				
				2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
				 - 
			Canagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				2-(4-Fluorophenyl)thiophene
				 - 
			Canagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				2-(Chloromethyl)-4-methylquinazoline
				 - 
			Linagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				2,5-Dichlorobenzooxazole 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				2-[(5-Bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene
				 - 
			Canagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyrimidinyl)Methyl]
				 - 
			Alogliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone
				 - 
			Prasugrel intermediates
			 | 
		
		 | 
		
			
				 
				
				2-Cyano-5-fluorobenzyl bromide
				 - 
			Trelagliptin intermediate
			 | 
		
		 | 
		
			
				 
				
				2-Cyanobenzyl bromide
				 - 
			Alogliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				2-oxo-2,4,5,6,7,7a-hexahydrothieno [3, 2-c] pyridine. Hydrochloride
				 - 
			Prasugrel intermediates
			 | 
		
		 | 
		
			
				 
				
				3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
				 - 
			Sitagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone
				 - 
			Aripiprazole intermediates
			 | 
		
		 | 
		
			
				 
				
				3-amino-1-adamantanol 
				 - 
			Vildagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				3-Ethoxy-4-ethoxycarbonyl phenylacetic acid
				 - 
			Repaglinide intermediates
			 | 
		
		 | 
		
			
				 
				
				4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate) 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate) 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate) 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				4-(4-Aminophenyl)morpholin-3-one
				 - 
			Rivaroxaban intermediates
			 | 
		
		 | 
		
			
				 
				
				4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether
				 - 
			Dapagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				4,5,6,7-Tetrahydrothieno[3,2,c] pyridine hydrochloride
				 - 
			Prasugrel intermediates
			 | 
		
		 | 
		
			
				 
				
				4,6-Dichloro-2-(propylthio)pyrimidin-5-amine
				 - 
			Ticagrelor intermediates
			 | 
		
		 | 
		
			
				 
				
				5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone
				 - 
			Apixaban intermediates
			 | 
		
		 | 
		
			
				 
				
				5-Chlorobenzooxazole-2-thiol 
				 - 
			Suvorexant Intermediates
			 | 
		
		 | 
		
			
				 
				
				5-Chlorothiophene-2-carboxylic acid
				 - 
			Rivaroxaban intermediates
			 | 
		
		 | 
		
			
				 
				
				5-Iodo-2-methylbenzoic acid
				 - 
			Canagliflozin intermediates
			 | 
		
		 | 
		
			
				 
				
				6-Chloro-3-methyluracil
				 - 
			Alogliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				7-hydroxy-3,4-Dihydro-2(1H)-quinolinone
				 - 
			Aripiprazole intermediates
			 | 
		
		 | 
		
			
				 
				
				8-Bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione
				 - 
			Linagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
				 - 
			Linagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				Alogliptin Benzoate
				 - 
			Alogliptin INN
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid
				 - 
			Sitagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				Boc-3-Hydroxy-1-adamantyl-D-glycine
				 - 
			Saxagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				Canagliflozin hemihydrate
				 - 
			Canagliflozin
anti-diabetics
SGLT2 inhibitors
			 | 
		
		 | 
		
			
				 
				
				Cyclopropyl 2-fluorobenzyl ketone
				 - 
			Prasugrel intermediates
			 | 
		
		 | 
		
			
				 
				
				Dabigatran etexilate 
				 - 
			Dabigatran
Cardiovasculars
			 | 
		
		 | 
		
			
				 
				
				Daclatasvir (BMS-790052) 
				 - 
			API for HCV
			 | 
		
		 | 
		
			
				 
				
				Dapagliflozin 
				 - 
			Dapagliflozin
anti-diabetics
SGLT2 inhibitors
			 | 
		
		 | 
		
			
				 
				
				Diethyl (tosyloxy)methylphosphonate
				 - 
			Tenofovir intermediates
			 | 
		
		 | 
		
			
				 
				
				Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane
				 - 
			intermediate
			 | 
		
		 | 
		
			
				 
				
				ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate
				 - 
			Apixaban intermediates
			 | 
		
		 | 
		
			
				 
				
				Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
				 - 
			Apixaban intermediates
			 | 
		
		 | 
		
			
				 
				
				lifenacin succinate 
				 - 
			API
			 | 
		
		 | 
		
			
				 
				
				Linagliptin
				 - 
			Linagliptin
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				L-Prolinamide
				 - 
			Vildagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
				 - 
			Sitagliptin intermediates
			 | 
		
		 | 
		
			
				 
				
				Picolinic acid 
				 - 
			Fine Chemicals
			 | 
		
		 | 
		
			
				 
				
				Prasugrel
				 - 
			Prasugrel 
Cardiovasculars
			 | 
		
		 | 
		
			
				 
				
				R-(+)-9-(2-Hydroxypropyl)adenine
				 - 
			Tenofovir intermediates
			 | 
		
		 | 
		
			
				 
				
				Repaglinide
				 - 
			 Repaglinide
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				Riociguat 
				 - 
			api 
			 | 
		
		 | 
		
			
				 
				
				Rivaroxaban
				 - 
			Rivaroxaban
Cardiovasculars
			 | 
		
		 | 
		
			
				 
				
				Sitagliptin  phosphate monohydrate
				 - 
			Sitagliptin   INN
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				Sofosbuvir 
				 - 
			API for HCV
			 | 
		
		 | 
		
			
				 
				
				Suvorexant (MK-4305) 
				 - 
			API for nervous system
			 | 
		
		 | 
		
			
				 
				
				Teneligliptin HBr 
				 - 
			Teneligliptin
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				Ticagrelor
				 - 
			 Ticagrelor
Cardiovasculars
			 | 
		
		 | 
		
			
				 
				
				Trelagliptin succinate 
				 - 
			Trelagliptin
anti-diabetics
			 | 
		
		 | 
		
			
				 
				
				Vildagliptin
				 - 
			vildagliptin INN
anti-diabetics
			 | 
		
		 | 
		 |